RecruitingCoronary Artery Disease (CAD)Ischemic Heart Disease
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAFLEX CRUZ).
Sponsor: Fundación EPIC
You may qualify if…
- ✓ ≥ 18 years old and;
- ✓ Patients treated with SUPRAFLEX CRUZ according to routine hospital practice and following instructions for use
- ✓ Patients with multivessel coronary artery disease (understood as that which affects more than one territory of the major epicardial coronary arteries - anterior descending, circumflex, right coronary artery) who is treated with more than 1 stent under study in lesions located in more than 1 of the aforementioned arteries.
- ✓ Substudy: Patients with Ejection Fraction \<45% by Echocardiography
- ✓ Informed consent signed
You may not qualify if…
- ✕ Not meet inclusion criteria
- ✕ Contraindication for antiplatelet treatment
- ✕ Patient life expectancy less than 12 months
Source: ClinicalTrials.gov · NCT05617599 · last updated 2025-12-16